Untargeted Metabolomics and Steroid Signatures in Urine of Male Pattern Baldness Patients after Finasteride Treatment for a Year
Male pattern baldness (MPB) has been associated with dihydrotestosterone (DHT) expression. Finasteride treats MPB by inhibiting 5-alpha reductase and blocking DHT production. In this study, we aimed to identify metabolic differences in urinary metabolomics profiles between MPB patients after a one-y...
Main Authors: | Yu Ra Lee, Eunju Im, Haksoon Kim, Bark Lynn Lew, Woo-Young Sim, Jeongae Lee, Han Bin Oh, Ki Jung Paeng, Jongki Hong, Bong Chul Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/10/4/131 |
Similar Items
-
Alterations in Pattern Baldness According to Sex: Hair Metabolomics Approach
by: Yu Ra Lee, et al.
Published: (2021-03-01) -
Finasteride and androgenic alopecia; from therapeutic options to medical implications
by: Ion G. Motofei, et al.
Published: (2020-05-01) -
Transcutaneous application of ultrasound enhances the effects of finasteride in a murine model of androgenic alopecia
by: Jaeho Kim, et al.
Published: (2022-04-01) -
Photosensitivity reaction induced by finasteride
by: Takayuki Yamada
Published: (2022-05-01) -
Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage
by: Elizângela Faustino Da Mata, et al.
Published: (2020-03-01)